The immunodeficiency of patients living with HIV leads to the limited production of inflammatory factors, and after treatment, IL-17a, the only inflammatory factor that increased, also dropped significantly, this might lead to further containment of tissue damage. Here, IL17A is linked to immunodeficiency disease.